Corpus Intelligence IC Memo — MONONGALIA GENERAL HOSPITAL 2026-04-26 03:45 UTC
IC Memo — MONONGALIA GENERAL HOSPITAL
Investment Committee Memorandum | WV | 160 beds | Grade C | EBITDA uplift $11.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MONONGALIA GENERAL HOSPITAL

CCN 510024 | MONONGALIA, WV | 160 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MONONGALIA GENERAL HOSPITAL is a 160-bed suburban community hospital in MONONGALIA, WV with $155.1M in net patient revenue and a -5.3% operating margin. The hospital serves a payer mix of 33.6% Medicare, 4.1% Medicaid, and 62.3% commercial.

Thesis: Undervalued. Our ML models identify $11.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.3% to 2.1% (+736bps).

Net Revenue HCRIS$155.1M
Current EBITDA COMPUTED$-8.2M
Operating Margin COMPUTED-5.3%
Occupancy HCRIS53.9%
Revenue / Bed COMPUTED$969K
Net-to-Gross HCRIS29.8%
Distress Probability ML48.0%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
16
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -5.3% places it below the state median. Among 16 size-comparable peers (80-320 beds), the median margin is 3.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (80-320), prioritizing same-state peers. 16 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MONONGALIA GENERAL HOSPITAL (Target)WV160$155.1M-5.3%
UNITED HOSPITAL CENTERWV232$516.4M9.4%
WHEELING HOSPITALWV189$411.4M-8.5%
CAMDEN-CLARK MEMORIAL HOSPITALWV256$357.5M-8.0%
CITY HOSPITAL INC.WV163$304.2M-2.8%
PRINCETON COMMUNITY HOSPITALWV115$290.2M12.8%
THOMAS MEMORIAL HOSPITALWV176$209.0M26.7%
WEIRTON MEDICAL CENTERWV127$182.4M9.4%
RALEIGH GENERAL HOSPITALWV300$181.8M-6.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.3M+210bp18mo
Cost to Collect4.5%2.5%$3.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.9M+122bp9mo
Clean Claim Rate88.0%96.0%$99K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.3M
Cost to Collect
$3.1M
Denial Rate Reduction
$3.1M
A/R Days Reduction
$1.9M
Clean Claim Rate
$99K
Total EBITDA Uplift$11.4M
Current EBITDA$-8.2M
+ RCM Uplift+$11.4M
Pro Forma EBITDA$3.2M
Current Margin-5.3%
Pro Forma Margin2.1%
WC Released (1x)$5.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.6M$60.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.6M$62.1M0.00x-100.0%
Bull Case9.0x11.0x$-11.3M$95.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.3M$101.1M0.00x-100.0%
Bear Case11.0x10.0x$-13.8M$7.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.8M$3.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 16 hospitals with 80-320 beds
  • Same-state prioritization (n=17)
  • Comp margins: P25=-8.2% / P50=3.4% / P75=10.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.